MedTrace Logo

Baby Iron Bioavailability Study

NCT03754543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-07-16

No results posted yet for this study

Summary

The overall objective of this trial is to investigate the iron bioavailability from new infant cereals in Malawian infants.

Conditions

  • Iron Bioavailability

Interventions

OTHER

Labeled iron salt Fe54

Ferrous fumarate enriched with Fe 54 isotopes contains 2.25 mg of iron source and 13.5 mg of Vitamin C per serving

OTHER

Labeled iron salt Fe57

Ferrous fumarate enriched with Fe 57 isotopes contains 2.25 mg of iron source and 13.5 mg of Vitamin C per serving

OTHER

Labeled iron salt Fe58

Ferrous bisglycinate enriched with Fe 58 isotopes contains 2.25 mg of iron source and 13.5 mg of Vitamin C per serving

Sponsors & Collaborators

  • Swiss Federal Institute of Technology

    collaborator OTHER

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Kamija Phiri, Prof. · Kamuzu University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
6 Months
Max Age
14 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2019-06-12
Completion
2019-06-12

Countries

  • Malawi

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03754543 on ClinicalTrials.gov